Isabelle Martin‐Toutain
- Internal Medicine top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 4
-
- Platelet Disorders and Treatments 4
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Systemic Lupus Erythematosus Research 4
-
- Heparin-Induced Thrombocytopenia and Thrombosis 3
-
- Clinical Laboratory Practices and Quality Control 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Sepsis Diagnosis and Treatment 2
- Co-authors
- Corinne FrèreGuillaume HékimianGuillaume LebretonAlain CombesAnnick AnkriPaul MasiMatthieu SchmidtManon Lejeune
- Partner nations
- FranceUnited StatesJapan
In The Last Decade
Isabelle Martin‐Toutain
15 papers receiving 275 citations
Peers
Comparison fields: 5 of 49
- Internal Medicine 43
- Infectious Diseases 144
- Hematology 61
- Neurology 69
- Rheumatology 43
Countries citing papers authored by Isabelle Martin‐Toutain
This map shows the geographic impact of Isabelle Martin‐Toutain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Martin‐Toutain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Martin‐Toutain more than expected).
Fields of papers citing papers by Isabelle Martin‐Toutain
This network shows the impact of papers produced by Isabelle Martin‐Toutain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Martin‐Toutain. The network helps show where Isabelle Martin‐Toutain may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Martin‐Toutain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 17 | |
| 4 | 2020 | 92 | |
| 5 | 2020 | 55 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 33 | |
| 8 | 2018 | 2 | |
| 9 | 2017 | 0 | |
| 10 | 2015 | 18 | |
| 11 | 2015 | 1 | |
| 12 | 2011 | 7 | |
| 13 | 2011 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2008 | 17 | |
| 16 | 2007 | 25 | |
| 17 | [Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis]. | 2004 | 2 |
About Isabelle Martin‐Toutain
Isabelle Martin‐Toutain is a scholar working on Hematology, Internal Medicine and Rheumatology, having authored 17 papers that have together received 283 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (4 papers), COVID-19 Clinical Research Studies (4 papers), Systemic Lupus Erythematosus Research (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Clinical Laboratory Practices and Quality Control (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Internal Medicine (43 citations), Infectious Diseases (144 citations) and Hematology (61 citations). Isabelle Martin‐Toutain has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Corinne Frère, Guillaume Hékimian, Guillaume Lebreton, Alain Combes, Annick Ankri, Paul Masi, Matthieu Schmidt, Manon Lejeune, Ania Nieszkowska and Marc Pineton de Chambrun. Their work appears in journals such as Circulation, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.